In this episode of Pointellis, Adlai Goldberg explores the life-changing world of cancer diagnosis and the path to full remission with Asaf Adler, Operations Senior Manager with EY.

Asaf Adler, EY Americas Senior Manager for Consulting, Business Consulting, Supply Chain & Operations, faced among the hardest patient challenges imaginable: stage 4 melanoma and lung cancer. But, today, as a cancer survivor, he’s optimistic about the state of cancer treatments. In this podcast, Adlai Goldberg, EY Social and Commercial Innovation Life Sciences Leader, speaks with Asaf about his experience finding out he had cancer to his discovery of individual-targeted treatments, his journey to remission and overall advancements in the life science sector.

Summer 2021 is a milestone in cancer treatment, as Phase 2 of the mRNA cancer vaccine (BioNTech) is introduced to its first patient. Asaf and Adlai share their excitement and hope around this amazing era of hope for cancer treatment.

Asaf’s own remarkable story underscores how quickly the clinical science is advancing and the profound impact these treatments have not only on the lives of current patients, but also to the loved ones surrounding them.